Adipolin/CTRP12 acts as a biomarker of coronary artery disease and protects against pathological vascular remodeling.

29 August 2017 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Vascular remodelling Vascular remodelling ESC Premium Access ESC Congress 2017

ESC 365 is supported by

ESC 365 is supported by